Myeloproliferative disorders (polycythemia, essential thrombocythemia, CML)Kim, S. Y., Bae, S. H., Bang, S. M., Eom, K. S., Hong, J., Jang, S., Jung, C. W., Kim, H. J., Kim, H. Y., Kim, M. K., Kim, S. J., Mun, Y. C., Nam, S. H., Park, J., Won, J. H., & Choi, C. W. (2021). The 2020 revision of the guidelines for the management of myeloproliferative neoplasms. The Korean journal of internal medicine, 36(1), 45–62. https://doi.org/10.3904/kjim.2020.319